Community/Retail

Drinking or eating from cans or bottles lined with Bisphenol A (BPA) could raise your blood pressure.

ASHP today honored Patricia Clancy Kienle, R.Ph., M.P.A., FASHP, with its Board of Directors Award for Distinguished Leadership in Pharmacy Practice during the opening session of the association's 49th Midyear Clinical Meeting in Anaheim, CA.

Merck announced a definitive agreement to acquire Cubist Pharmaceuticals, a biopharmaceutical company focused on superbugs.

If you have high blood pressure and purchase an over-the-counter medication, you may be getting more than you bargained for. That's the word from experts who caution that some medications taken over the counter can have a negative impact on blood pressure. If patients are unknowingly taking medications that elevate blood pressure, it could undermine efforts to keep blood pressure in a safe range.

The Islamic State in Iraq and Syria (ISIS) is using social media to recruit Israeli Arab pharmacy and medical students studying in Jordan to work in its field hospitals, according to Business Insider.

New study results dispute the belief that diabetic patients with mild or non-obstructive coronary artery disease have a lower risk of major adverse cardiovascular events and death than their counterparts with obstructive disease.

Astellas Pharma, Inc, announced that its license agreement with Janssen Biotech, Inc, to develop and commercialize ASP015K, Astellas' oral Janus Kinase inhibitor, will end effective January 15, 2015.

Shrina Patel, a P4 student at the Philadelphia College of Pharmacy at the University of the Sciences, discusses what has influenced her the most in school.

Josh Garcia, a P4 student at the Philadelphia College of Pharmacy at the University of the Sciences, discusses what has influenced him the most in school.

Researchers at the American Epilepsy Society meeting reported important strides in the understanding of epilepsy, including identification of new therapeutic targets in the brain, as discussed by Esther Krook-Magnuson, PhD, as well as improved understanding of the factors involved in sudden death of patients with epilepsy, and a greater recognition of the benefits of neurosurgery in patients with epilepsy.

Several new antiepileptic drugs have recently been approved in the United States. In a symposium at the American Epilepsy Society in Seattle, Washington, Professor Martin J. Brodie, MD, director of the epilepsy unit of the Western Infirmary in Glasgow, Scotland, discussed some considerations with ezogabine and eslicarbazepine.

Mark Cook, MD, of the University of Melbourne, and Brian Litt, MD, of the Penn Epilepsy Center and the Center for Neuroengineering and Therapeutics at the University of Pennsylvania, discuss how new devices, big data, and massive online competitions are enabling prediction of seizures before they start.

The Islamic State in Iraq and Syria is using social media to recruit Israeli Arab pharmacy and medical students studying in Jordan to work in its field hospitals.

The National Association of Chain Drug Stores Foundation celebrated its 16th Annual Foundation Dinner last evening in New York City, New York. The dinner raised a record $1.9 million, which will continue to fuel the Foundation's patient-centered care research agenda, which was on full display during the gala event. Walgreen Co. and Duane Reade Inc. were the premier sponsors of last evening's event. More than 100 companies from a diverse range of industries sponsored the event.

The American Society of Health-System Pharmacists Midyear Clinical Meeting is still billed as a "can't miss" event.

The media has been quick to discuss research findings on vitamin D supplementation's potential role in combating osteoporosis, correcting deficiency in chronic kidney disease, improving heart health, and extending life, which raises the question of whether patients should be screened routinely for vitamin D deficiency.

The Bristol-Myers Squibb Foundation today announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus and hepatitis C virus infection by focusing on the most vulnerable, high-risk patient populations.

Eun Jeong Choi, a P4 student at the Philadelphia College of Pharmacy at the University of the Sciences, discusses how students can impact the future of pharmacy.

S. L. Moshé, MD, of the Albert Einstein College of Medicine and Montefiore Medical Center, discusses the importance of creating disease-specific models of epilepsy in animal models for understanding and treating specific epilepsy subtypes.

The links between epilepsy and other diseases offer clues for early treatment. Frances E. Jensen, MD, past AES president and professor at Cornell Medical School, describes these links, and what they mean for future epilepsy treatment modalities.

Joe Moose, PharmD, of Moose Pharmacy, discusses the role of the pharmacist in prevention and reducing readmissions among acute coronary syndrome patients.

Kristen Park, MD, assistant professor of pediatrics and neurology at the University of Colorado, discussed the potential risks and benefits of alternative therapies for epilepsy, including medical marijuana.

Daniel Boulos, a P4 student at the Philadelphia College of Pharmacy at the University of the Sciences, discusses how students can impact the future of pharmacy.

In light of new data that shows the 2014-2015 flu season could be severe, the US Centers for Disease Control and Prevention is urging immediate influenza vaccination for all unvaccinated individuals, as well as prompt antiviral drug treatment for those who develop flu and have a high risk of complications.

When will we begin to see globalization with pharmacy practice ventures that will result in an internationalization of pharmacist licensure?

As pharmacists' ability to tease out more comprehensive information from clinical trials has increased, it has become evident that social and biologic factors interact to produce paradoxical health differences between men and women, especially on cardiovascular outcomes.

Shrina Patel, a P4 student at the Philadelphia College of Pharmacy at the University of the Sciences, discusses how students can impact the future of pharmacy.

Treating patients with status epilepticus is a challenging balance of minimizing the risk of medication adverse events while managing the serious dangers of status epilepticus itself.

Antiepileptic medications are a broad category of drugs with many potential adverse events. In this session, Eugen Trinka, MD, MSc, reviews the most common adverse events associated with these therapies.

Understanding the recommendations of evidence-based guidelines is an important component of treating patients with therapies backed by the best available evidence.